Sentences with phrase «of cardiac failure»
Apparently, this group can intervene at the moment of cardiac failure, but keep other cells alive by artificial circulation of oxygenated fluid.
http://www.slaw.ca/
7 Mancini DM, Lejentel TH, Factor S, Sonnenblick E. Central and peripheral components of cardiac failure.
There are two types of cardiac failure or myopathy that occur in dogs.
This form of cardiac failure is quite rare in dogs.
Toxins can attack the valves of the heart, diminishing their capacity and increasing the likelihood of cardiac failure.
There have been scientific studies that indicate that a few cases of cardiac failure, particularly in boxers, are due to a deficiency in the amino acid L - carnitine.
Not exact matches
• Cardiac Dimensions, a Kirkland, Wash. - based developer of minimally invasive treatments for patients with heart failure, raised $ 39 million Series B funding.
As for the rest of the unpronounceable ingredients if you'd like to be nauseous, have irritated skin, or consume a chemical listed with «use caution in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy» then just go ahead and grab that iced coffee from McDonald's to go (just incase you have to shit, puke, or have a heart attack).
A large population - based study from Canada found that the risk of severe maternal morbidities ---- defined as hemorrhage that requires hysterectomy or transfusion, uterine rupture, anesthetic complications, shock, cardiac arrest, acute renal failure, assisted ventilation, venous thromboembolism, major infection, or in - hospital wound disruption or hematoma ---- was increased threefold for cesarean delivery as compared with vaginal delivery (2.7 % versus 0.9 %, respectively)(7).
For example, he's used it along with a calcium - tracking dye in cardiac muscle cells from a rat, to image the sparks and waves of calcium ions that can trigger deadly arrhythmias during heart failure.
A late - breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funCardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funFailure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funfailure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump funcardiac arrest in patients with heart failure and preserved ejection fraction (pump funfailure and preserved ejection fraction (pump function).
«We've taken the failures from conventional cardiac resynchronization therapy and we're fixing over 80 percent of them.»
Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example.
Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury and help physicians select a prophylactic therapeutic strategy against sudden cardiac death in hemodialysis patients.Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury and help physicians select a prophylactic therapeutic strategy against sudden cardiac death in hemodialysis patients.cardiac death in hemodialysis patients.»
He added: «An abnormal Q wave indicates the presence of previous myocardial infarction or serious myocardial injury responsible for low cardiac output, heart failure and / or potentially fatal arrhythmias.
The patients have been followed since July 2016, and none of their cardiac issues have resolved, but symptoms have improved following treatment for heart failure or atrial fibrillation, Dr. Carta says.
For a high - risk heart failure patient, Farra says, it might be possible for the device to monitor the heart for signs of a heart attack and release drugs to decrease damage to the heart muscle during a cardiac event.
Additional studies will follow to validate the value of stem cell - based regenerative solutions in addressing abnormal cardiac motion in heart failure, ultimately leading to improved patient care.
Amit Patel, a cardiac surgeon and researcher at the University of Pittsburgh, has completed three clinical trials in Asia and South America that included more than 100 heart - failure patients.
Death from heart failure can often be attributed to direct cardiac causes such as heart failure symptoms, inadequate blood supply and irregular heartbeats; however, the noncardiac causes of heart failure death, such as cancer, are becoming increasingly recognized as researchers learn more about their association with the disease.
Findings from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of failure in patients with heart failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of failure and a preserved ejection fraction in a study funded by the National Heart, Lung and Blood Institute, National Institutes of Health.
Marc Semigran, MD, medical director of the MGH Heart Failure and Cardiac Transplant Service adds, «The ability to safely administer inhaled NO chronically to heart failure patients could improve the lives of many of the millions of patients with secondary pulmonary hypertension.Failure and Cardiac Transplant Service adds, «The ability to safely administer inhaled NO chronically to heart failure patients could improve the lives of many of the millions of patients with secondary pulmonary hypertension.failure patients could improve the lives of many of the millions of patients with secondary pulmonary hypertension.»
However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health - related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.
Past research, Kopf said, shows the elevating circulating aldosterone levels are associated with high blood pressure, blood clot formation, thickening of the heart muscle (called cardiac hypertrophy) and congestive heart failure.
A cardiac arrest is the cessation of normal circulation of the blood due to failure of the ventricles of the heart to contract effectively during systole.
«This research is important in that it may advance the application of widely available cardiac biomarkers to identify CKD patients at the highest risk of developing heart failure, the most common cardiovascular complication in this patient population,» said Dr. Bansal.
The result is, among other things, a lifelong restriction of cardiac function, or even heart failure.
The 10 - year Warfarin and Aspirin for Reduced Cardiac Ejection Fraction (WARCEF) trial is the largest randomized, double - blind comparison of aspirin and warfarin (also known by its brand name Coumadin) for heart failure, following 2,305 heart failure patients whose heart muscle pumps less oxygen - rich blood into the body, known as reduced ejection fraction, at 168 study sites in 11 countries on three continents.
Both phases of cardiac function are important: impaired contraction leads to systolic heart failure, while impaired relaxation leads to diastolic heart failure.
Anthracycline drugs, such as doxorubicin, are known to cause heart failure because they cause changes in the DNA structure of the heart muscle cells, leading to irreversible cardiac damage.
Still, Larsen said the findings raise important questions about what the appropriate surveillance should be for heart problems post-cancer treatment and suggested that more frequent cardiac imaging may be warranted in some patients to detect signs of heart failure earlier.
Identified additional novel epigenetic and transcriptional regulators of cardiac hypertrophy and heart failure pathogenesis
Correcting the timing of heart contractions through cardiac resynchronization therapy can be a lifesaver for people with advanced heart failure.
For example, we identified that acetyl - lysine «reader» proteins of the BET family play a critical role in cardiac transcription and heart failure pathogenesis.
Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells.
A national leader in basic cardiology research, the CVI has the only basic research center in New England dedicated to rhythm disorders of the heart (cardiac arrhythmias), heart enlargement (hypertrophy) and heart failure.
March 4, 2013 Donald Rowley, MD, 1923 - 2013 Donald Rowley, MD, a pioneer in discovering how the immune system functions and the inventor of the gel electrode, a crucial tool that monitors cardiac activity, died at his home early Sunday, Feb. 24, after a long battle with congestive heart failure.
In fact, cardiac arrest (complete stop of heart) is completely different from the condition of heart failure.
Her work on the genetic mechanisms of cardiomyopathies and muscular dystrophies has identified several genes that are important for cardiac and skeletal muscle membrane stability and produced insights into how heart failure and muscle dysfunction occur.
Thus, these animals exhibit premature cardiac arrhythmias and stiffening of the arterial wall, and cardiac failure appears to be the main cause of death; yet these tissues are not burdened with an abnormally - high burden of p16Ink4a - senescent cells, and accordingly, ablation p16Ink4a - positive senescent cells in these animals had little tissue - specific or survivorship phenotypic impact.
Comprehensive cardiac services include cardiac diagnostic testing and intervention, cardiac rehabilitation, heart failure management, congenital heart disease management and programs for lipid management, management of hypertension and disease prevention.
While a post-doctoral fellow at the University of Cincinnati College of Medicine, he succeeded in establishing a variety of useful transgenic animal models to elucidate mechanisms of cardiac excitation - contraction coupling and heart failure.
He is past associate editor of the Journal of Clinical Investigation, past editorial board member of the Journal of Biological Chemistry and served as a member of the Cardiac Hypertrophy and Heart Failure NIH Study Section.
Results Of the 40 449 patients included in the study, 16201 (40.0 %) were women; mean (SD) age of the cohort was 72.5 (10.1) years, and the mean CHA2DS2 - VASc (cardiac failure or dysfunction, hypertension, age ≥ 75 years [doubled], diabetes mellitus, stroke [doubled]-- vascular disease, age 65 - 74 years, and sex category [female]-RRB- score was 3.3 at baselinOf the 40 449 patients included in the study, 16201 (40.0 %) were women; mean (SD) age of the cohort was 72.5 (10.1) years, and the mean CHA2DS2 - VASc (cardiac failure or dysfunction, hypertension, age ≥ 75 years [doubled], diabetes mellitus, stroke [doubled]-- vascular disease, age 65 - 74 years, and sex category [female]-RRB- score was 3.3 at baselinof the cohort was 72.5 (10.1) years, and the mean CHA2DS2 - VASc (cardiac failure or dysfunction, hypertension, age ≥ 75 years [doubled], diabetes mellitus, stroke [doubled]-- vascular disease, age 65 - 74 years, and sex category [female]-RRB- score was 3.3 at baseline.
Symposia VI: Cardiovascular Benefits of Exercise: Insights from Human Studies The session will cover improving exercise tolerance in heart failure, reversal of impaired cardiac function in obese adolescents, the effect of exercise on left ventricular compliance and diastolic function in the elderly and attenuating premature cardiovascular aging in Type 2 diabetes through exercise.
«We also showed that, after heart failure, this combination of genes significantly improves cardiac function.»
Most importantly, patients who received chest RT are at greater risk of cardiac complications, including coronary artery disease, valvular heart disease, congestive heart failure, and pericardial disease.
The loss of contractile cells and the inability of the adult mammalian heart to regenerate is a major cause of cardiac dysfunction and heart failure.
In addition, HER2 is expressed in many normal tissues, giving systemic HER2 - targeted antibody therapy the potential to cause toxicity in a subset of patients, including cardiac myopathy, congestive heart failure, and pulmonary toxicity [14], [15].
«Since patients with heart failure are normally elderly, their cardiac stem cells aren't very healthy,» Sadia Mohsin, one of the study authors and a postdoctoral research scholar at San Diego State University's Heart Institute, explained in a news release from the American Heart Association (AHA).